| Property | Value |
|---|
| Working Groups |  Hemmer |
| Subproject | None |
| Open Access |  Yes |
| Publication Type | Journal Article |
| Peer Reviewed | Yes |
| PMID |  28002679 |
| DOI |  10.1056/NEJMoa1601277 |
| Publication Year | 2017 |
| Title | Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.  |
| Journal | The New England journal of medicine |
| ISSN | 0028-4793 |
| ESSN | 1533-4406 |
| URL | https://www.ncbi.nlm.nih.gov/pubmed/?term=28002679%5Buid%5D |
| Pages | 221-234 |
| Issue | 3 |
| Volume | 376 |
| Journal Abbreviation | N Engl J Med |
| Authors | Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L |
| First Author | Hauser SL |
| Last Author | Kappos L |
| Scholia |  Wikidata-based representation at Scholia |
External Resources
Q40400262https://www.wikidata.org/wiki/Q40400262
Wikidata ID
